Progress toward liquid biopsies in pediatric solid tumors

Daniel A. Weiser, Diana C. West-Szymanski, Ellen Fraint, Shoshana Weiner, Marco A. Rivas, Carolyn W.T. Zhao, Chuan He, Mark A. Applebaum

Research output: Contribution to journalReview article

Abstract

Pediatric solid tumors have long been known to shed tumor cells, DNA, RNA, and proteins into the blood. Recent technological advances have allowed for improved capture and analysis of these typically scant circulating materials. Efforts are ongoing to develop “liquid biopsy” assays as minimally invasive tools to address diagnostic, prognostic, and disease monitoring needs in childhood cancer care. Applying these highly sensitive technologies to serial liquid biopsies is expected to advance understanding of tumor biology, heterogeneity, and evolution over the course of therapy, thus opening new avenues for personalized therapy. In this review, we outline the latest technologies available for liquid biopsies and describe the methods, pitfalls, and benefits of the assays that are being developed for children with extracranial solid tumors. We discuss what has been learned in several of the most common pediatric solid tumors including neuroblastoma, sarcoma, Wilms tumor, and hepatoblastoma and highlight promising future directions for the field.

Original languageEnglish (US)
JournalCancer and Metastasis Reviews
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Pediatrics
Biopsy
Neoplasms
Technology
Hepatoblastoma
Wilms Tumor
Neuroblastoma
Sarcoma
Blood Proteins
RNA
DNA
Therapeutics

Keywords

  • Cell-free DNA
  • Epigenetics
  • Liquid biopsy
  • Next-generation sequencing
  • Pediatric solid tumors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Weiser, D. A., West-Szymanski, D. C., Fraint, E., Weiner, S., Rivas, M. A., Zhao, C. W. T., ... Applebaum, M. A. (Accepted/In press). Progress toward liquid biopsies in pediatric solid tumors. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-019-09825-1

Progress toward liquid biopsies in pediatric solid tumors. / Weiser, Daniel A.; West-Szymanski, Diana C.; Fraint, Ellen; Weiner, Shoshana; Rivas, Marco A.; Zhao, Carolyn W.T.; He, Chuan; Applebaum, Mark A.

In: Cancer and Metastasis Reviews, 01.01.2019.

Research output: Contribution to journalReview article

Weiser, DA, West-Szymanski, DC, Fraint, E, Weiner, S, Rivas, MA, Zhao, CWT, He, C & Applebaum, MA 2019, 'Progress toward liquid biopsies in pediatric solid tumors', Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-019-09825-1
Weiser, Daniel A. ; West-Szymanski, Diana C. ; Fraint, Ellen ; Weiner, Shoshana ; Rivas, Marco A. ; Zhao, Carolyn W.T. ; He, Chuan ; Applebaum, Mark A. / Progress toward liquid biopsies in pediatric solid tumors. In: Cancer and Metastasis Reviews. 2019.
@article{fb29e2881e2d41b6903b1b5ec9db4426,
title = "Progress toward liquid biopsies in pediatric solid tumors",
abstract = "Pediatric solid tumors have long been known to shed tumor cells, DNA, RNA, and proteins into the blood. Recent technological advances have allowed for improved capture and analysis of these typically scant circulating materials. Efforts are ongoing to develop “liquid biopsy” assays as minimally invasive tools to address diagnostic, prognostic, and disease monitoring needs in childhood cancer care. Applying these highly sensitive technologies to serial liquid biopsies is expected to advance understanding of tumor biology, heterogeneity, and evolution over the course of therapy, thus opening new avenues for personalized therapy. In this review, we outline the latest technologies available for liquid biopsies and describe the methods, pitfalls, and benefits of the assays that are being developed for children with extracranial solid tumors. We discuss what has been learned in several of the most common pediatric solid tumors including neuroblastoma, sarcoma, Wilms tumor, and hepatoblastoma and highlight promising future directions for the field.",
keywords = "Cell-free DNA, Epigenetics, Liquid biopsy, Next-generation sequencing, Pediatric solid tumors",
author = "Weiser, {Daniel A.} and West-Szymanski, {Diana C.} and Ellen Fraint and Shoshana Weiner and Rivas, {Marco A.} and Zhao, {Carolyn W.T.} and Chuan He and Applebaum, {Mark A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10555-019-09825-1",
language = "English (US)",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Progress toward liquid biopsies in pediatric solid tumors

AU - Weiser, Daniel A.

AU - West-Szymanski, Diana C.

AU - Fraint, Ellen

AU - Weiner, Shoshana

AU - Rivas, Marco A.

AU - Zhao, Carolyn W.T.

AU - He, Chuan

AU - Applebaum, Mark A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pediatric solid tumors have long been known to shed tumor cells, DNA, RNA, and proteins into the blood. Recent technological advances have allowed for improved capture and analysis of these typically scant circulating materials. Efforts are ongoing to develop “liquid biopsy” assays as minimally invasive tools to address diagnostic, prognostic, and disease monitoring needs in childhood cancer care. Applying these highly sensitive technologies to serial liquid biopsies is expected to advance understanding of tumor biology, heterogeneity, and evolution over the course of therapy, thus opening new avenues for personalized therapy. In this review, we outline the latest technologies available for liquid biopsies and describe the methods, pitfalls, and benefits of the assays that are being developed for children with extracranial solid tumors. We discuss what has been learned in several of the most common pediatric solid tumors including neuroblastoma, sarcoma, Wilms tumor, and hepatoblastoma and highlight promising future directions for the field.

AB - Pediatric solid tumors have long been known to shed tumor cells, DNA, RNA, and proteins into the blood. Recent technological advances have allowed for improved capture and analysis of these typically scant circulating materials. Efforts are ongoing to develop “liquid biopsy” assays as minimally invasive tools to address diagnostic, prognostic, and disease monitoring needs in childhood cancer care. Applying these highly sensitive technologies to serial liquid biopsies is expected to advance understanding of tumor biology, heterogeneity, and evolution over the course of therapy, thus opening new avenues for personalized therapy. In this review, we outline the latest technologies available for liquid biopsies and describe the methods, pitfalls, and benefits of the assays that are being developed for children with extracranial solid tumors. We discuss what has been learned in several of the most common pediatric solid tumors including neuroblastoma, sarcoma, Wilms tumor, and hepatoblastoma and highlight promising future directions for the field.

KW - Cell-free DNA

KW - Epigenetics

KW - Liquid biopsy

KW - Next-generation sequencing

KW - Pediatric solid tumors

UR - http://www.scopus.com/inward/record.url?scp=85076862009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076862009&partnerID=8YFLogxK

U2 - 10.1007/s10555-019-09825-1

DO - 10.1007/s10555-019-09825-1

M3 - Review article

C2 - 31836951

AN - SCOPUS:85076862009

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

ER -